![[BioSnap] GSK Korea expands indications for RSV vaccine ‘Arexvi’](https://img.yna.co.kr/etc/inner/KR/2026/07/02/AKR20260702155400017_01_i_P2.jpg)
[BioSnap] GSK Korea expands indications for RSV vaccine ‘Arexvi’
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Park Sang-hyun = GSK Korea announced that the number of people eligible for vaccination with the respiratory syncytial virus (RSV) vaccine 'Arexvi' has been expanded.
📰 Related Articles
U.S. Blue Owl Private Loan Fund requests redemption from investors worth 7 trillion won in the second quarter
Yonhap
Democratic Congo Ebola death toll exceeds 400... Ugandan ship confirms Marburg infection
Yonhap
Lee Seong-hoon, Secretary of Land, Infrastructure and Transport, is the new LH president.
Yonhap